Completed Clinical Trials

Dendritic Cell-based Immunotherapy in Mesothelioma

By April 24, 2017 No Comments


Malignant Pleural Mesothelioma

Estimated Enrollment: 10

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: MEC-2005-269|PMR-MM05-001

Study First Received: January 20, 2006

Last Updated: November 15, 2010

Estimated Primary Completion Date: September 2009


Primary Outcome Measures:


Sponsors and Collaborators:

Erasmus Medical Center

Website Link:

Leave a Reply

Call Now ButtonCall Now